Oncogenic virus in oral squamous cell carcinoma and the role of oncolytic HSV-1 viro-immunotherapy as an emerging treatment

Oral Oncol. 2022 Oct:133:106021. doi: 10.1016/j.oraloncology.2022.106021. Epub 2022 Jul 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Carcinoma, Squamous Cell* / pathology
  • Carcinoma, Squamous Cell* / therapy
  • Head and Neck Neoplasms* / therapy
  • Herpesvirus 1, Human*
  • Humans
  • Immunotherapy
  • Mouth Neoplasms* / therapy
  • Oncogenic Viruses
  • Oncolytic Virotherapy*
  • Squamous Cell Carcinoma of Head and Neck / therapy